ClinicalTrials.gov
public full text
Public Domain
Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine
This protocol describes the analysis of the Adelphi Real World (ARW) Migraine Disease Specific Programme(TM) 2022, a cross-sectional study which used both physician and patient surveys to assess the perception of the acute treatment for migraine attacks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China#1182970
- Investigation of the Effect of Cold Application in Migraine#829137
- Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)#867547
- A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.#1363166
- The Identification and Characterization of Autonomic Dysfunction in Migraineurs With and Without Auras#896633
Record · ID 1183172
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive